Novel omni-50 crispr nuclease-rna complexes
AssigneesLiat ROCKAH, EmendoBio Inc.
InventorsLior Izhar, Liat Rockah, Nadav Marbach Bar
Life of this patent
Estimating the term…
Abstract
A composition comprising a non-naturally occurring RNA molecule, the RNA molecule comprising an RNA scaffold portion, the RNA scaffold portion having the structure: crRNA repeat sequence portion-Linker portion-tracrRNA portion; wherein the RNA scaffold portion forms a complex with and targets an OMNI-50 CRISPR nuclease to a DNA target site having complementarity to a guide sequence portion of the RNA molecule.
Claims63
A composition comprising a non-naturally occurring RNA molecule, the RNA molecule comprising a crRNA repeat sequence portion and a guide sequence portion, wherein the RNA molecule forms a complex with and targets an OMNI-50 nuclease to a DNA target site in the presence of a tracrRNA sequence, wherein the tracrRNA sequence is encoded by a tracrRNA portion of the RNA molecule or a tracrRNA portion of a second RNA molecule.
A composition comprising a non-naturally occurring RNA molecule, the RNA molecule comprising a tracrRNA portion, wherein the RNA molecule forms a complex with and targets an OMNI-50 nuclease to a DNA target site in the presence of a crRNA repeat sequence portion and a guide sequence portion, wherein the crRNA repeat sequence portion and the guide sequence portion are encoded by the RNA molecule or a second RNA molecule.
The composition of any one of claims 29-34, wherein the crRNA repeat sequence portion has at least 95% sequence identity to any one of SEQ ID NOs:
- 8, 23, 24, and 25.
A composition comprising a non-naturally occurring RNA molecule, the RNA molecule comprising an RNA scaffold portion, the RNA scaffold portion having the structure:
- crRNA repeat sequence portion-Linker portion-tracrRNA portion;
- wherein the RNA scaffold portion froms a complex with and targets an OMNI-50 CRISPR nuclease to a DNA target site having complimentarity to a guide sequence portion of the RNA molecule.
The composition of claim 43, the polynucleotide linker has a sequence of GAAA. The composition of any one of claims 42-44, wherein the tracrRNA anti-repeat sequence portion is less than 19 nucleotides in length, preferably 14-18 nucleotides in length.
Dependencies are inferred from the claim text.